drugset / Trial / NCT04825574
Study for Patients Previously Treated in Avapritinib Clinical Trials
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label extension study to provide long term safety data for GIST patients who are deriving clinical benefit from avapritinib upon the completion of avapritinib clinical trials.
Timeline
- Start
- 2021-05-21
- Primary completion
- 2023-11-23
- Completion
- 2023-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Avapritinib | Small molecule | — | — |